Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-18-043515
Date:2018-07-18
Issuer: FIBROGEN INC (FGEN)
Original Submission Date:

Reporting Person:

NEFF THOMAS B
C/O FIBROGEN, INC.
409 ILLINOIS ST. SAN FRANCISCO, CA 94158

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2018-07-18 M 10,320 a $3.60 2,822,033 direct
COMMON STOCK 2018-07-18 S 8,100 d $65.19 2,813,933 direct
COMMON STOCK 2018-07-18 S 10,800 d $65.70 2,803,133 direct
COMMON STOCK 2018-07-18 S 918 d $65.48 104,892 indirect
COMMON STOCK 2018-07-19 M 10,320 a $3.60 2,813,453 direct
COMMON STOCK 2018-07-19 S 18,800 d $64.34 2,794,653 direct
COMMON STOCK 2018-07-19 S 100 d $64.80 2,794,553 direct
COMMON STOCK 2018-07-19 S 918 d $64.27 103,974 indirect
COMMON STOCK 2018-07-18 0 $0.00 19,500 indirect
COMMON STOCK 2018-07-18 0 $0.00 60,946 indirect f7
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 3.6 2018-07-18 deemed execution date M 10,320 (d) 2019-03-11 common stock 10,320 $3.60 299,261 direct
STOCK OPTION (RIGHT TO BUY) 3.6 2018-07-19 deemed execution date M 10,320 (d) 2019-03-11 common stock 10,320 $3.60 288,941 direct
Footnotes
IDfootnote
f1 shares sold pursuant to a 10b5-1 plan.
f2 the shares were sold at prices ranging from $64.40 to $65.35. the reporting person will provide upon request to the sec, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
f3 the shares were sold at prices ranging from $65.40 to $66.00. the reporting person will provide upon request to the sec, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
f4 the shares were sold at prices ranging from $65.15 to $65.90. the reporting person will provide upon request to the sec, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
f5 the shares were sold at prices ranging from $63.75 to $64.70. the reporting person will provide upon request to the sec, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
f6 the shares were sold at prices ranging from $63.75 to $64.50. the reporting person will provide upon request to the sec, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
f7 the shares are held by biogrowth partners, lp. the reporting person is the sole general partner of biogrowth partners, lp and has sole voting and dispositive power over the shares held by biogrowth partners, lp.
f8 fully vested.
WhaleWisdom Logo

Elevate your investments